OBJECTIVES: p120ctn is a component of the catenin family. To date, there have only been two studies examining expression levels of p120ctn in oral squamous cell carcinoma (OSCC). MATERIALS AND METHODS: Paraffined specimens of 113 OSCCs and 12 of normal mucosa were examined by immunohistochemistry. Frozen samples of 20 OSCCs and 5 of normal mucosa were examined by Western blot (WB). Results were correlated with clinicopathological parameters. Five cell lines were examined by immunofluorescence, immunocytochemistry, and WB to show immunoreactivity and cellular localization of p120ctn. RESULTS: Altered p120ctn expression was observed in 109/113 cases of OSCC. Heterogenous cytoplasmic/nuclear expression was associated with loss of membranous distribution (88/113 cases). Complete loss of expression was noted in 21/113 cases. Increased cytoplasmic expression was evident in all positive cases, without significant correlation among p120ctn staining/pattern and grading/stage. Reduction/absence of p120ctn expression was related to poor prognosis (P < .05). CONCLUSION: p120ctn delocalization/loss of expression could be an independent prognostic marker in OSCC.
OBJECTIVES:p120ctn is a component of the catenin family. To date, there have only been two studies examining expression levels of p120ctn in oral squamous cell carcinoma (OSCC). MATERIALS AND METHODS: Paraffined specimens of 113 OSCCs and 12 of normal mucosa were examined by immunohistochemistry. Frozen samples of 20 OSCCs and 5 of normal mucosa were examined by Western blot (WB). Results were correlated with clinicopathological parameters. Five cell lines were examined by immunofluorescence, immunocytochemistry, and WB to show immunoreactivity and cellular localization of p120ctn. RESULTS: Altered p120ctn expression was observed in 109/113 cases of OSCC. Heterogenous cytoplasmic/nuclear expression was associated with loss of membranous distribution (88/113 cases). Complete loss of expression was noted in 21/113 cases. Increased cytoplasmic expression was evident in all positive cases, without significant correlation among p120ctn staining/pattern and grading/stage. Reduction/absence of p120ctn expression was related to poor prognosis (P < .05). CONCLUSION:p120ctn delocalization/loss of expression could be an independent prognostic marker in OSCC.
Authors: Karam El-Bayoumy; Neil D Christensen; Jiafen Hu; Raphael Viscidi; Douglas B Stairs; Vonn Walter; Kun-Ming Chen; Yuan-Wan Sun; Joshua E Muscat; John P Richie Journal: Cancer Prev Res (Phila) Date: 2020-05-20
Authors: Neil D Christensen; Kun-Ming Chen; Jiafen Hu; Douglas B Stairs; Yuan-Wan Sun; Cesar Aliaga; Karla K Balogh; Hannah Atkins; Debra Shearer; Jingwei Li; Sarah A Brendle; Krishne Gowda; Shantu Amin; Vonn Walter; Raphael Viscidi; Karam El-Bayoumy Journal: Chem Biol Interact Date: 2020-11-10 Impact factor: 5.168
Authors: Mario Dioguardi; Giovanni Di Gioia; Giorgia Apollonia Caloro; Giorgia Capocasale; Khrystyna Zhurakivska; Giuseppe Troiano; Lucio Lo Russo; Lorenzo Lo Muzio Journal: Dent J (Basel) Date: 2019-05-01
Authors: Andrea Santarelli; Marco Mascitti; Lucio Lo Russo; Davide Sartini; Giuseppe Troiano; Monica Emanuelli; Lorenzo Lo Muzio Journal: Int J Mol Sci Date: 2018-03-24 Impact factor: 5.923
Authors: Khrystyna Zhurakivska; Giuseppe Troiano; Vito Carlo Alberto Caponio; Mario Dioguardi; Claudia Arena; Lorenzo Lo Muzio Journal: Nutrients Date: 2018-10-19 Impact factor: 5.717